DAPSONE (Pacific Pharma)
Welcome to the PulseAid listing for the DAPSONE drug offered from Pacific Pharma. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pacific Pharma |
NON-PROPRIETARY NAME: | dapsone |
SUBSTANCE NAME: | DAPSONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-10-18 |
END MARKETING DATE: | 0000-00-00 |
DAPSONE HUMAN PRESCRIPTION DRUG Details:
Item Description | DAPSONE from Pacific Pharma |
LABELER NAME: | Pacific Pharma |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/g) |
START MARKETING DATE: | 2017-10-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60758-670_f5f79832-62c0-4eb2-ad5b-d4796f04df3c |
PRODUCT NDC: | 60758-670 |
APPLICATION NUMBER: | NDA021794 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers: